Laser acupuncture for treating constipation in women with irritable bowel syndrome
Laser Acupuncture for Treatment of Female Patients With Irritable Bowel Syndrome:RCT
This study tests if laser acupuncture can help women with constipation from irritable bowel syndrome feel better compared to a fake treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 35 Years to 40 Years |
| Sex | Female |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Giza) |
| Trial ID | NCT05757037 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of laser acupuncture on female patients suffering from constipation-predominant irritable bowel syndrome (IBS-C). It aims to address the complex symptoms associated with IBS-C, including abdominal pain and bloating, which are often exacerbated by delayed gut transit. Participants will be randomly assigned to either a treatment group receiving actual laser acupuncture or a control group receiving sham treatment. The study will utilize specific acupoints to assess the efficacy of this alternative therapy compared to standard pharmacological treatments.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 20-35 who meet the diagnostic criteria for constipation-predominant irritable bowel syndrome.
Not a fit: Patients with organic diseases causing constipation, severe psychiatric disorders, or those who are pregnant or lactating may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a non-pharmacological treatment option for women suffering from IBS-C, potentially improving their quality of life.
How similar studies have performed: While the use of acupuncture for IBS has been explored, the specific application of laser acupuncture in this context is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All participants will meet diagnostic criteria (Rome IV) for IBS-C * Their age will range from 20-35 years old * Their body mass index (BMI) will range from \>18.5kg/m2 and \<29.9kg/m2 Exclusion Criteria: * Taking medications known to cause constipation * Any organic diseases that might induce constipation such as colorectal cancer, metabolic disorders, multiple sclerosis, or neurological disorders * Organic diseases of the small or large intestine such as ulcerative colitis and Crohn's disease * A history of gastrointestinal surgery (other than appendectomy or cholecystectomy) * Mechanical obstruction * Serious concomitant disease of the heart, liver, or kidney or diabetes * Pregnant or lactating women * Severe psychiatric disorders * Knowledgeable of acupoints and meridians that might unblind the treatment.
Where this trial is running
Giza
- Egypt , Giza — Giza, Egypt (Recruiting)
Study contacts
- Study coordinator: sara Magdy Ahmed, lecturer
- Email: saramagdy87@cu.edu.eg
- Phone: 01063998331
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.